Literature DB >> 34453888

Interaction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progression of tauopathy.

Lulu Jiang1, Weiwei Lin2, Cheng Zhang3, Peter E A Ash1, Mamta Verma1, Julian Kwan2, Emily van Vliet1, Zhuo Yang1, Anna Lourdes Cruz1, Samantha Boudeau1, Brandon F Maziuk1, Shuwen Lei1, Jaehyup Song1, Victor E Alvarez4, Stacy Hovde5, Jose F Abisambra6, Min-Hao Kuo5, Nicholas Kanaan7, Melissa E Murray8, John F Crary9, Jian Zhao10, Ji-Xin Cheng10, Leonard Petrucelli8, Hu Li3, Andrew Emili2, Benjamin Wolozin11.   

Abstract

The microtubule-associated protein tau oligomerizes, but the actions of oligomeric tau (oTau) are unknown. We have used Cry2-based optogenetics to induce tau oligomers (oTau-c). Optical induction of oTau-c elicits tau phosphorylation, aggregation, and a translational stress response that includes stress granules and reduced protein synthesis. Proteomic analysis identifies HNRNPA2B1 as a principle target of oTau-c. The association of HNRNPA2B1 with endogenous oTau was verified in neurons, animal models, and human Alzheimer brain tissues. Mechanistic studies demonstrate that HNRNPA2B1 functions as a linker, connecting oTau with N6-methyladenosine (m6A) modified RNA transcripts. Knockdown of HNRNPA2B1 prevents oTau or oTau-c from associating with m6A or from reducing protein synthesis and reduces oTau-induced neurodegeneration. Levels of m6A and the m6A-oTau-HNRNPA2B1 complex are increased up to 5-fold in the brains of Alzheimer subjects and P301S tau mice. These results reveal a complex containing oTau, HNRNPA2B1, and m6A that contributes to the integrated stress response of oTau.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; METTL3; RNA methylation; RNA translation; fibrils; lamin; neurodegeneration; nuclear envelope; stress granules; tau oligomerization

Mesh:

Substances:

Year:  2021        PMID: 34453888      PMCID: PMC8541906          DOI: 10.1016/j.molcel.2021.07.038

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   19.328


  70 in total

1.  Lamin Dysfunction Mediates Neurodegeneration in Tauopathies.

Authors:  Bess Frost; Farah H Bardai; Mel B Feany
Journal:  Curr Biol       Date:  2015-12-24       Impact factor: 10.834

Review 2.  Regulation of signaling proteins in the brain by light.

Authors:  Raphael Lamprecht
Journal:  Prog Neurobiol       Date:  2019-06-11       Impact factor: 11.685

3.  limma powers differential expression analyses for RNA-sequencing and microarray studies.

Authors:  Matthew E Ritchie; Belinda Phipson; Di Wu; Yifang Hu; Charity W Law; Wei Shi; Gordon K Smyth
Journal:  Nucleic Acids Res       Date:  2015-01-20       Impact factor: 16.971

4.  PRMT7 Interacts with ASS1 and Citrullinemia Mutations Disrupt the Interaction.

Authors:  Mamta Verma; Ramya Chandar M Charles; Baskar Chakrapani; Mohane Selvaraj Coumar; Gayathri Govindaraju; Arumugam Rajavelu; Sreenivas Chavali; Arunkumar Dhayalan
Journal:  J Mol Biol       Date:  2017-06-03       Impact factor: 5.469

5.  Reducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo.

Authors:  Daniel J Apicco; Peter E A Ash; Brandon Maziuk; Chelsey LeBlang; Maria Medalla; Ali Al Abdullatif; Antonio Ferragud; Emily Botelho; Heather I Ballance; Uma Dhawan; Samantha Boudeau; Anna Lourdes Cruz; Daniel Kashy; Aria Wong; Lisa R Goldberg; Neema Yazdani; Cheng Zhang; Choong Y Ung; Yorghos Tripodis; Nicholas M Kanaan; Tsuneya Ikezu; Pietro Cottone; John Leszyk; Hu Li; Jennifer Luebke; Camron D Bryant; Benjamin Wolozin
Journal:  Nat Neurosci       Date:  2017-11-20       Impact factor: 24.884

6.  Tau interactome mapping based identification of Otub1 as Tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo.

Authors:  Peng Wang; Gerard Joberty; Arjan Buist; Alexandre Vanoosthuyse; Ilie-Cosmin Stancu; Bruno Vasconcelos; Nathalie Pierrot; Maria Faelth-Savitski; Pascal Kienlen-Campard; Jean-Noël Octave; Marcus Bantscheff; Gerard Drewes; Diederik Moechars; Ilse Dewachter
Journal:  Acta Neuropathol       Date:  2017-01-12       Impact factor: 17.088

7.  Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.

Authors:  Juha Laurén; David A Gimbel; Haakon B Nygaard; John W Gilbert; Stephen M Strittmatter
Journal:  Nature       Date:  2009-02-26       Impact factor: 49.962

8.  Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance.

Authors:  Casey Cook; Yari Carlomagno; Tania F Gendron; Judy Dunmore; Kristyn Scheffel; Caroline Stetler; Mary Davis; Dennis Dickson; Matthew Jarpe; Michael DeTure; Leonard Petrucelli
Journal:  Hum Mol Genet       Date:  2013-08-19       Impact factor: 6.150

9.  LRP1 is a master regulator of tau uptake and spread.

Authors:  Jennifer N Rauch; Gabriel Luna; Elmer Guzman; Morgane Audouard; Collin Challis; Youssef E Sibih; Carolina Leshuk; Israel Hernandez; Susanne Wegmann; Bradley T Hyman; Viviana Gradinaru; Martin Kampmann; Kenneth S Kosik
Journal:  Nature       Date:  2020-04-01       Impact factor: 49.962

10.  Tau Oligomers and Fibrils Exhibit Differential Patterns of Seeding and Association With RNA Binding Proteins.

Authors:  Lulu Jiang; Jian Zhao; Ji-Xin Cheng; Benjamin Wolozin
Journal:  Front Neurol       Date:  2020-09-30       Impact factor: 4.003

View more
  13 in total

Review 1.  Epitranscriptomic dynamics in brain development and disease.

Authors:  Andrew M Shafik; Emily G Allen; Peng Jin
Journal:  Mol Psychiatry       Date:  2022-04-26       Impact factor: 15.992

2.  Tau oligomers are linked to m6A-RNA.

Authors:  Kim Baumann
Journal:  Nat Rev Mol Cell Biol       Date:  2021-10       Impact factor: 94.444

Review 3.  Tau liquid-liquid phase separation in neurodegenerative diseases.

Authors:  Solomiia Boyko; Witold K Surewicz
Journal:  Trends Cell Biol       Date:  2022-02-15       Impact factor: 21.167

4.  The Expression of hnRNP A2/B1 in Benign and Malignant Lung Lesions and Its Early Diagnosis Value in NSCLC.

Authors:  Wenchao Gu; Xiwen Gao; Linxun Wang; Guoping Deng; Jiaru Huang; Junxia Yang; Yuan Liu; Qun Liu; Hongyang Sang
Journal:  Contrast Media Mol Imaging       Date:  2022-10-05       Impact factor: 3.009

Review 5.  Exploring the Diverse Functional and Regulatory Consequences of Alternative Splicing in Development and Disease.

Authors:  M Brandon Titus; Adeline W Chang; Eugenia C Olesnicky
Journal:  Front Genet       Date:  2021-11-24       Impact factor: 4.599

Review 6.  Tau mRNA Metabolism in Neurodegenerative Diseases: A Tangle Journey.

Authors:  Paulo J da Costa; Malika Hamdane; Luc Buée; Franck Martin
Journal:  Biomedicines       Date:  2022-01-23

7.  HNRNPA2B1 Demonstrates Diagnostic and Prognostic Values Based on Pan-Cancer Analyses.

Authors:  Chaoyang Chen; Lipeng Huang; Qingyu Sun; Zhichen Yu; Xiaoyan Wang; Liang Bu
Journal:  Comput Math Methods Med       Date:  2022-04-27       Impact factor: 2.809

8.  Rational design of self-assembled RNA nanostructures for HIV-1 virus assembly blockade.

Authors:  Na Qu; Yachen Ying; Jinshan Qin; Antony K Chen
Journal:  Nucleic Acids Res       Date:  2022-05-06       Impact factor: 19.160

Review 9.  Virus-Induced Membrane Fusion in Neurodegenerative Disorders.

Authors:  Carolina Osorio; Adonis Sfera; Jonathan J Anton; Karina G Thomas; Christina V Andronescu; Erica Li; Rayan W Yahia; Andrea García Avalos; Zisis Kozlakidis
Journal:  Front Cell Infect Microbiol       Date:  2022-03-24       Impact factor: 6.073

Review 10.  Synaptic Disruption by Soluble Oligomers in Patients with Alzheimer's and Parkinson's Disease.

Authors:  Berenice A Gutierrez; Agenor Limon
Journal:  Biomedicines       Date:  2022-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.